Literature DB >> 4904755

Transplanted carcinoma in an immunosuppressed patient.

B Matter, C F Zukoski, D A Killen, E Ginn.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4904755     DOI: 10.1097/00007890-197001000-00021

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  15 in total

1.  Immunosuppression and malignancy.

Authors: 
Journal:  Br Med J       Date:  1972-09-23

2.  Proceedings: The effect of immunosuppression on cancer.

Authors:  I Penn; T E Starzl
Journal:  Proc Natl Cancer Conf       Date:  1972

Review 3.  Iatrogenic alterations of immunologic surveillance in man and their influence on malignancy.

Authors:  T E Starzl; I Penn; C W Putnam; C G Groth; C G Halgrimson
Journal:  Transplant Rev       Date:  1971

4.  Immunotherapy in patients with melanoma.

Authors:  H F Seiger; W W Shingleton; R S Metzgar; C E Buckley
Journal:  Ann Surg       Date:  1973-09       Impact factor: 12.969

Review 5.  [Immunosuppression, genesis and growth of malignant tumours].

Authors:  H E Reis
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1972

Review 6.  Cancer after transplantation.

Authors:  A G Sheil
Journal:  World J Surg       Date:  1986-06       Impact factor: 3.352

7.  Tumour induction as a consequence of immunosuppression after renal transplantation.

Authors:  P Winter; G Schoeneich; W D Miersch; H U Klehr
Journal:  Int Urol Nephrol       Date:  1997       Impact factor: 2.370

8.  Transplantation of tumour with a kidney graft.

Authors:  A D Barnes; M Fox
Journal:  Br Med J       Date:  1976-06-12

Review 9.  Donor transmitted and de novo cancer after liver transplantation.

Authors:  Rajeev Desai; James Neuberger
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

10.  Transferral of malignancy as a complication of organ transplantation: an insuperable problem?

Authors:  L Harvey; M Fox
Journal:  J Clin Pathol       Date:  1981-02       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.